ARTICLE | Clinical News
BSD-2000 Hyperthermia System: Phase I/II started
December 24, 2012 8:00 AM UTC
BSD began the open-label, German Phase I/II HyRec trial to evaluate the BSD-2000 Hyperthermia System in combination with 5-fluorouracil (5-FU) and oxaliplatin chemotherapy and radiotherapy in about 59...